RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RTTR

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2017/01/30	23 : 00	Marketwired	Ritter Pharmaceuticals to Ring Today's Nasdaq Stock Market Closing Bell to Kick-off Lactose Intolerance Awareness Month	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/30	22 : 48	GlobeNewswire Inc.	Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) to Ring The Nasdaq Stock Market Closing Bell	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/28	06 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/28	05 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/23	23 : 00	Marketwired	Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics ...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/17	22 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/17	22 : 00	Marketwired	Ritter Pharmaceuticals Appoints William Merino, Ph.D., to its Board of Directors	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/01/04	02 : 34	Marketwired	Ritter Pharmaceuticals Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published in Proceedings of the National ...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/12/17	06 : 37	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/12/01	08 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/12/01	08 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/12/01	08 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/16	07 : 28	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/07	22 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/07	22 : 30	Marketwired	Ritter Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/07	20 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/05	05 : 06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/11/01	05 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/28	05 : 32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/27	19 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/26	21 : 00	Marketwired	Ritter Pharmaceuticals, Inc. Prices $5,000,000 Public Offering of Common Stock	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/26	19 : 13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/26	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/17	21 : 30	Marketwired	Ritter Pharma Concludes Last Patient Visit of Its Phase 2b/3 Clinical Trial of RP-G28 for the Treatment of Lactose Intoleranc...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/06	05 : 29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/10/06	01 : 06	Marketwired	Ritter Pharmaceuticals Presents at the 4th Microbiome R&D Business Collaboration Forum	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/08/24	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/08/15	21 : 30	Marketwired	Ritter Pharmaceuticals Completes Enrollment for Phase 2b/3 Trial of RP-G28 in Lactose Intolerance	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/08/12	05 : 55	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2016/08/08	21 : 30	Marketwired	Ritter Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update	NASDAQ:RTTR	Ritter Pharmaceuticals Inc